ADRA2A Alpha-2 adrenergic receptors mediate the catecholamine-induced inhibition of adenylate cyclase through the action of G proteins. The rank order of potency for agonists of this receptor is oxymetazoline Belongs to the G-protein coupled receptor 1 family. Adrenergic receptor subfamily. ADRA2A sub-subfamily. Note: This description may include information from UniProtKB.
Protein type: GPCR, family 1; Membrane protein, integral; Membrane protein, multi-pass; Receptor, GPCR
Chromosomal Location of Human Ortholog: 10q25.2
Cellular Component:  basolateral plasma membrane; cytoplasm; integral component of plasma membrane; plasma membrane; receptor complex
Molecular Function:  alpha-1B adrenergic receptor binding; alpha-2C adrenergic receptor binding; alpha2-adrenergic receptor activity; epinephrine binding; heterotrimeric G-protein binding; norepinephrine binding; protein binding; protein heterodimerization activity; protein homodimerization activity; protein kinase binding; thioesterase binding
Biological Process:  actin cytoskeleton organization; activation of protein kinase activity; activation of protein kinase B activity; adenylate cyclase-activating adrenergic receptor signaling pathway; adenylate cyclase-activating G protein-coupled receptor signaling pathway; adenylate cyclase-inhibiting adrenergic receptor signaling pathway; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; adrenergic receptor signaling pathway; cellular response to hormone stimulus; G protein-coupled receptor signaling pathway; glucose homeostasis; intestinal absorption; negative regulation of calcium ion transmembrane transporter activity; negative regulation of calcium ion transport; negative regulation of calcium ion-dependent exocytosis; negative regulation of epinephrine secretion; negative regulation of insulin secretion; negative regulation of insulin secretion involved in cellular response to glucose stimulus; negative regulation of lipid catabolic process; negative regulation of norepinephrine secretion; phospholipase C-activating adrenergic receptor signaling pathway; platelet activation; positive regulation of cell migration; positive regulation of cell proliferation; positive regulation of cytokine production; positive regulation of epidermal growth factor-activated receptor activity; positive regulation of MAP kinase activity; positive regulation of MAPK cascade; positive regulation of membrane protein ectodomain proteolysis; positive regulation of potassium ion transport; positive regulation of wound healing; Ras protein signal transduction; receptor transactivation; regulation of insulin secretion; regulation of smooth muscle contraction; regulation of vasoconstriction; Rho protein signal transduction
Reference #:  P08913 (UniProtKB)
Alt. Names/Synonyms: ADA2A; ADRA2; ADRA2A; ADRA2R; ADRAR; adrenergic, alpha-2A-, receptor; adrenoceptor alpha 2A; Alpha-2 adrenergic receptor subtype C10; alpha-2-adrenergic receptor, platelet type; Alpha-2A adrenergic receptor; Alpha-2A adrenoceptor; Alpha-2A adrenoreceptor; Alpha-2AAR; alpha-2AAR subtype C10; ALPHA2AAR; ZNF32
Gene Symbols: ADRA2A
Molecular weight: 50,647 Da
Basal Isoelectric point: 9.75  Predict pI for various phosphorylation states
Select Structure to View Below

ADRA2A

Protein Structure Not Found.


Cross-references to other databases:  STRING  |  cBioPortal  |  Wikipedia  |  Reactome  |  neXtProt  |  Protein Atlas  |  BioGPS  |  Pfam  |  RCSB PDB  |  Phospho3D  |  Phospho.ELM  |  NetworKIN  |  GeneCards  |  UniProtKB  |  Entrez-Gene  |  GenPept  |  Ensembl Gene